Five Ways Ontada Is Powering Speed and Precision

When it comes to cancer, time is more than valuable. It’s vital.  

For patients, speed can make the difference between hope and heartbreak. For life sciences companies, accelerating the development and delivery of therapies means faster access to potentially lifesaving treatments. Ontada is helping to meet this urgency through innovation, research and data-driven solutions.  

These five key activations demonstrate how Ontada is powering the speed of oncology care across healthcare.  

1. Partnering with the FDA to Understand Rare Cancers

The U.S. Food and Drug Administration (FDA) selected Ontada to support research into the natural history of rare cancers in community oncology settings. By leveraging real-world data (RWD) from The US Oncology Network and Onmark practices, the study aims to close knowledge gaps where clinical trials are limited or unavailable. 

This collaboration is deepening our understanding of some of the most challenging and under-studied cancer types — and may help accelerate patient access to innovative therapies. 

2. Unlocking the Power of AI with Microsoft Azure

Ontada’s partnership with Microsoft Azure AI is advancing oncology research by dramatically improving the speed and scale of analyzing unstructured healthcare data — up to four times faster.  

This breakthrough allows life sciences companies to generate high-quality, real-world evidence (RWE) more quickly, supporting faster drug development, timely provider education and more effective engagement strategies, all with the patient at the center. 

3. Advancing Precision Medicine with Caris Life Sciences

Ontada’s strategic partnership with Caris Life Sciences brings together multimodal data to advance precision medicine. By integrating molecular data with clinical data from the electronic health record (EHR), researchers can more rapidly identify critical molecular biomarkers and accelerate the discovery and development of targeted therapies.  

This collaboration is helping to make personalized care more precise, timely and impactful for patients.  

4. Delivering Insights Faster with the ON.Genuity^TM  Platform

Speed and reliability are essential in oncology research. ON.Genuity^TM  is a powerful data platform that curates high-quality RWD with the completeness and transparency life sciences companies need. 

By providing access to meaningful insights, ON.Genuity^TM empowers partners to make faster, more informed decisions. The platform serves as a trusted foundation for leading community oncology clinical datasets with advanced technology, capturing insights at point of care and delivering data with meaningful clinical depth.  

ON.Genuity^TM delivers a comprehensive and enhanced view of patient care spanning pre-diagnosis, treatment and survivorship, allowing us to provide unprecedented access to RWD at scale, with quality and speed. These real-word evidence and data solutions drive a deeper understanding of oncology care and advance research innovation. 

5. Creating a Seamless Ecosystem with iKnowMed®  

Ontada’s award-winning EHR, iKnowMed®, supports every step of the cancer care journey. iKnowMed®, an oncology-specific EHR, streamlines clinical workflows, reduces administrative burden and enables more informed treatment decisions.     

With mobile, on-the-go functionality and integrated services like precision-support technology and a secure patient portal, iKnowMed® is at the forefront of cancer care so providers can adapt to evolving oncology trends as they occur. With real-time access to patient data and clinical insights, iKnowMed® accelerates decision-making at the point of care — helping oncologists deliver timely, personalized treatment plans that can improve outcomes and reduce delays.

Innovation with Purpose 

We believe in a future where every cancer patient has faster access to better treatment options. Through innovation, trusted partnerships and a deep understanding of oncology, Ontada is helping to make that future a reality.